Steven Keith Burke - Net Worth and Insider Trading
Steven Keith Burke Net Worth
The estimated net worth of Steven Keith Burke is at least $851,060 dollars as of 2024-06-07. Steven Keith Burke is the SVP, Chief Medical Officer of Akebia Therapeutics Inc and owns about 695,840 shares of Akebia Therapeutics Inc (AKBA) stock worth over $744,549. Steven Keith Burke is also the SVP and Chief Medical Officer of Proteon Therapeutics Inc and owns about 3,188 shares of Proteon Therapeutics Inc (PRTO) stock worth over $106,511. Details can be seen in Steven Keith Burke's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Steven Keith Burke has not made any transactions after 2024-02-29 and currently still holds the listed stock(s).
Transaction Summary of Steven Keith Burke
Steven Keith Burke Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Steven Keith Burke owns 2 companies in total, including Akebia Therapeutics Inc (AKBA) , and Protara Therapeutics Inc (TARA) .
Click here to see the complete history of Steven Keith Burke’s form 4 insider trades.
Insider Ownership Summary of Steven Keith Burke
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| AKBA | Akebia Therapeutics Inc | 2024-02-29 | SVP & Chief Medical Officer |
| TARA | Protara Therapeutics Inc | 2014-10-21 | Sr. VP & Chief Medical Officer |
Steven Keith Burke Latest Holdings Summary
Steven Keith Burke currently owns a total of 2 stocks. Among these stocks, Steven Keith Burke owns 695,840 shares of Akebia Therapeutics Inc (AKBA) as of February 29, 2024, with a value of $744,549 and a weighting of 87.48%. Steven Keith Burke also owns 3,188 shares of Proteon Therapeutics Inc (PRTO) as of December 15, 2017, with a value of $106,511 and a weighting of 12.52%.
Latest Holdings of Steven Keith Burke
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| AKBA | Akebia Therapeutics Inc | 2024-02-29 | 695,840 | 1.07 | 744,549 |
| PRTO | Proteon Therapeutics Inc | 2017-12-15 | 3,188 | 33.41 | 106,511 |
Holding Weightings of Steven Keith Burke
Steven Keith Burke Form 4 Trading Tracker
According to the SEC Form 4 filings, Steven Keith Burke has made a total of 10 transactions in Akebia Therapeutics Inc (AKBA) over the past 5 years, including 1 buys and 9 sells. The most-recent trade in Akebia Therapeutics Inc is the sale of 7,169 shares on February 29, 2024, which brought Steven Keith Burke around $11,327.
According to the SEC Form 4 filings, Steven Keith Burke has made a total of 0 transactions in Proteon Therapeutics Inc (PRTO) over the past 5 years. The most-recent trade in Proteon Therapeutics Inc is the acquisition of 300 shares on December 15, 2017, which cost Steven Keith Burke around $22,560.
Insider Trading History of Steven Keith Burke
- 1
Steven Keith Burke Trading Performance
GuruFocus tracks the stock performance after each of Steven Keith Burke's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Steven Keith Burke is 111.41%. GuruFocus also compares Steven Keith Burke's trading performance to market benchmark return within the same time period. The performance of stocks bought by Steven Keith Burke within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Steven Keith Burke's insider trading performs compared to the benchmark.
Performance of Steven Keith Burke
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 60.09 | | | | | |
| Relative Return to S&P 500(%) | 56.21 | | | | | |
Steven Keith Burke Ownership Network
Steven Keith Burke Owned Company Details
What does Akebia Therapeutics Inc do?
Who are the key executives at Akebia Therapeutics Inc?
Steven Keith Burke is the SVP & Chief Medical Officer of Akebia Therapeutics Inc. Other key executives at Akebia Therapeutics Inc include SVP & Chief Business Officer Michel Dahan , SVP & General Counsel & Sec. Nicole R. Hadas , and director & CEO & President John P. Butler .
Akebia Therapeutics Inc (AKBA) Insider Trades Summary
Over the past 18 months, Steven Keith Burke made 6 insider transaction in Akebia Therapeutics Inc (AKBA) with a net sale of 127,765. Other recent insider transactions involving Akebia Therapeutics Inc (AKBA) include a net sale of 180,225 shares made by Michel Dahan , a net sale of 108,298 shares made by Nicole R. Hadas , and a net sale of 214,803 shares made by John P. Butler .
In summary, during the past 3 months, insiders sold 46,856 shares of Akebia Therapeutics Inc (AKBA) in total and bought 0 shares, with a net sale of 46,856 shares. During the past 18 months, 709,407 shares of Akebia Therapeutics Inc (AKBA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 709,407 shares.
Akebia Therapeutics Inc (AKBA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Akebia Therapeutics Inc Insider Transactions
Steven Keith Burke Mailing Address
Above is the net worth, insider trading, and ownership report for Steven Keith Burke. You might contact Steven Keith Burke via mailing address: 82 Willis Road, Sudbury Ma 01776.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
